GLUE vs TRMB · rev $13.2M vs P/E 26, rev $1.91B
Monte Rosa Therapeutics Inc (GLUE) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
GLUE currently screens at market cap $1.56B. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the GLUE and TRMB stock pages for the full models.
Not investment advice.